cilostazol Tablets, sustained release (SR) 100 mg, 200 mg

Dossier type
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
Manufacturer #18096
Since its establishment in the 1950s, the company has been enjoying the privilege of playing a major role as a forerunner in the East Asian pharmaceutical industry for over half a century. Based on the long-term goal, they strive for further growth and expansion. A strong alliance with the worldwide pharmaceutical companies allows the company to expand the market worldwide and cope with the challenging environment of the global pharmaceutical industry. Through active involvement in R&D activities, quality management, and overseas business, they fulfill the expectations of customers and shareholders.

Manufacturer usually replies in 5 days

Cilostazol is a medication used to treat intermittent claudication in peripheral vascular disease. Suppliers of cilostazol market it in the form of 50mg and 100mg tablets. The drug was first introduced into the pharmaceutical market in 1999 and has since then become a widely prescribed medication with over a million prescriptions of cilostazol registered yearly in the U.S. alone. The largest manufacturers of cilostazol globally include GlaxoSmithKline, Bristol-Myers Squibb, Bedford Laboratories, Takeda, Novartis, Mylan, Abbot, and Pfizer. Cilostazol suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cilostazol manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 56 (100mg) tablets of cilostazol fall into an approximate range of 15,00 EUR to 20,00 EUR.